| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 |
| filingDate |
2018-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81ac830e72bd9963c72c17c62da5299f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_677dfa5aa3c3912b21d2d9bff861e226 |
| publicationDate |
2019-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201902479-A |
| titleOfInvention |
Lewis dermatosis therapeutic agent containing pyrazoloquinoline derivative |
| abstract |
The invention provides a compound containing (S) -7- (2-methoxy-3,5-dimethylpyridin-4-yl) -1- (tetrahydrofuran-3-yl) -1H represented by formula (I) -Pyrazolo [4,3-c] quinolin-4 (5H) -one [Chem 1] Or a pharmacologically acceptable salt of Lewy body treatment agent. |
| priorityDate |
2017-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |